Cell
Volume 75, Issue 3, 5 November 1993, Pages 495-505
Journal home page for Cell

Article
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

https://doi.org/10.1016/0092-8674(93)90384-3Get rights and content

Abstract

The ubiquitin-dependent proteolytic pathway plays a major role in selective protein degradation. Ubiquitination of proteins requires the sequential action of the ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzymes (E2), and in some cases ubiquitin-protein ligases (E3s). The oncogenic human papillomavirus (HPV) types 16 and 18 utilize this cellular proteolytic system to target the tumor suppressor protein p53. The HPV E6 oncoprotein binds to a cellular protein of 100 kd, termed E6-associated protein (E6-AP). The E6-E6-AP complex specifically interacts with p53, resulting in the rapid ubiquitin-dependent degradation of p53. Here we report the purification and identification of the factors necessary for the E6-E6-AP-mediated ubiquitination of p53. The ubiquitination of p53 requires the E1 enzyme and a novel E2 in mammalian cells, while E3 activity is conferred by the E6-E6-AP complex. Furthermore, E6-AP appears to have ubiquitin-protein ligase activity in the absence of E6.

References (57)

  • J.-Y. Lin et al.

    Transformation by simian virus 40 does not involve the mutational activation of p53 to an oncogenic form

    Virology

    (1990)
  • D.I.H. Linzer et al.

    Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

    Cell

    (1979)
  • C.M. Pickart et al.

    Levels of active ubiquitin carrier proteins decline during erythroid maturation

    J. Biol. Chem.

    (1988)
  • M. Rechsteiner

    Natural substrates of the ubiquitin proteolytic pathway

    Cell

    (1991)
  • Y. Reiss et al.

    Affinity purification of ubiquitin-protein ligase on immobilized protein substrates

    J. Biol. Chem.

    (1990)
  • P. Sarnow et al.

    Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

    Cell

    (1982)
  • M. Scheffner et al.

    The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

    Cell

    (1990)
  • M.L. Sullivan et al.

    Cloning of a 16-kDa ubiquitin carrier protein from wheat and Arabidopsis thaliana

    J. Biol. Chem.

    (1991)
  • J.W. Tobias et al.

    Cloning and functional analysis of the ubiquitin-specific protease gene UBP1 of Saccharomyces cerevisiae

    J. Biol. Chem.

    (1991)
  • S.S. Wing et al.

    A rabbit reticulocyte ubiquitin carrier protein that supports ubiquitin-dependent proteolysis (E21 4k) is homologous to the yeast DNA repair gene RAD6

    J. Biol. Chem.

    (1992)
  • H. zur Hausen

    Human papillomaviruses in the pathogenesis of anogenital cancer

    Virology

    (1991)
  • B. Bartel et al.

    The recognition component of the N-end rule pathway

    EMBO J.

    (1990)
  • V. Chau et al.

    A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein

    Science

    (1989)
  • A. Ciechanover et al.

    Degradation of nuclear oncoproteins by the ubiquitin proteolysis system in vitro

  • T. Crook et al.

    p53 point mutation in HPV negative human cervical carcinoma cell lines

    Oncogene

    (1991)
  • L. Diller et al.

    p53 functions as a cell cycle control protein in osteosarcomas

    Mol. Cell. Biol.

    (1990)
  • R.J. Dohmen et al.

    The N-end rule is mediated by the UBC2(RAD6) ubiquitin-conjugating enzyme

  • N. Dyson et al.

    The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

    Science

    (1989)
  • Cited by (2070)

    View all citing articles on Scopus

    Present address: Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum, D-69017 Heidelberg, Federal Republic of Germany.

    View full text